Published in J Cardiovasc Pharmacol on June 01, 1999
Non-genomic actions of 17beta-oestradiol in mouse pancreatic beta-cells are mediated by a cGMP-dependent protein kinase. J Physiol (1999) 1.02
Sex differences in myocardial metabolism and cardiac function: an emerging concept. Pflugers Arch (2013) 0.92
Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am J Physiol Endocrinol Metab (2013) 0.89
Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade. Br J Pharmacol (2006) 0.85
Estrogen fails to facilitate resuscitation from ventricular fibrillation in male rats. Am J Transl Res (2015) 0.76
Wind-induced ventilation of the giant nests of the leaf-cutting ant Atta vollenweideri. Naturwissenschaften (2001) 5.66
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50
'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol (1996) 3.70
Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 3.15
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65
Context generalization in Drosophila visual learning requires the mushroom bodies. Nature (1999) 2.52
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol (1991) 2.34
Ontogeny constrains systemic protease inhibitor response in Nicotiana attenuata. J Chem Ecol (2001) 2.24
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett (1993) 2.14
Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med (1999) 2.13
Long-term outcome after thrombolysis in telemedical stroke care. Neurology (2007) 2.12
Solubilization of membrane proteins by sulfobetaines, novel zwitterionic surfactants. Anal Biochem (1978) 2.09
Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res (2001) 2.08
[Bilateral salivary gland swelling with pitfalls]. Med Klin (Munich) (1994) 2.03
Adrenal-sparing surgery for phaeochromocytoma. Br J Surg (1999) 1.96
Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A (1992) 1.93
Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med (1998) 1.92
TGN38/41 recycles between the cell surface and the TGN: brefeldin A affects its rate of return to the TGN. Mol Biol Cell (1993) 1.87
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
In situ detection of novel bacterial endosymbionts of Acanthamoeba spp. phylogenetically related to members of the order Rickettsiales. Appl Environ Microbiol (1999) 1.81
Temporal pattern of locomotor activity in Drosophila melanogaster. J Comp Physiol A (1999) 1.81
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol (2000) 1.73
Mushroom bodies suppress locomotor activity in Drosophila melanogaster. Learn Mem (1999) 1.71
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation (1992) 1.71
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol (2001) 1.68
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
The 'incidentaloma' of the pituitary gland. Is neurosurgery required? JAMA (1990) 1.65
The power law distribution for walking-time intervals correlates with the ellipsoid-body in Drosophila. J Neurogenet (2001) 1.65
Fast high-resolution magnetic resonance imaging demonstrates fractality of myocardial perfusion in microscopic dimensions. Circ Res (2001) 1.64
Protein microarrays for gene expression and antibody screening. Anal Biochem (1999) 1.64
Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. AJR Am J Roentgenol (2000) 1.62
Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun (1990) 1.61
Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med (2001) 1.60
Microbial diversity of marine sponges. Prog Mol Subcell Biol (2003) 1.59
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med (2013) 1.57
Low circulating androgens and mortality risk in heart failure. Heart (2009) 1.56
Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem (2000) 1.55
Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. Am J Physiol Heart Circ Physiol (2000) 1.53
Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol (1996) 1.48
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol (1999) 1.47
Marrow-mindedness: a perspective on neuropoiesis. Trends Neurosci (1999) 1.46
Direct measurement of spin-lattice relaxation times of phosphorus metabolites in human myocardium. Magn Reson Med (1992) 1.42
The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol (1999) 1.42
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia (2007) 1.41
Phylogenetic diversity among geographically dispersed Chlamydiales endosymbionts recovered from clinical and environmental isolates of Acanthamoeba spp. Appl Environ Microbiol (2000) 1.41
Fatal toxic epidermal necrolysis during suramin therapy. Eur J Cancer (1991) 1.41
Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol (1990) 1.41
Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut. Neurosci Lett (1992) 1.40
Leukemia in a child with a history of medulloblastoma. Pediatr Hematol Oncol (1991) 1.39
[Therapy-resistant hypertension--the endocrinological view]. MMW Fortschr Med (2007) 1.39
[Regional hyperthermic fibrinolytic perfusion in postoperative deep venous thrombosis of the leg]. Dtsch Med Wochenschr (1992) 1.38
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res (1999) 1.36
Subpopulations of GABAergic neurons in laminae I-III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience (1994) 1.36
Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging (2001) 1.35
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest (1995) 1.34
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry (2010) 1.33
Complement activation by recombinant adenoviruses. Gene Ther (2001) 1.31
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab (2009) 1.30
An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ (2008) 1.29
Simulated limnological effects of the Shasta Lake temperature control device. Environ Manage (2001) 1.26
Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer (2000) 1.23
Phylogenetic analysis of and oligonucleotide probe development for eikelboom type 021N filamentous bacteria isolated from bulking activated sludge. Appl Environ Microbiol (2000) 1.22
[Reliability and safety of intravitreal Ozurdex injections. The ZERO study]. Ophthalmologe (2014) 1.18
Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience (1993) 1.18
Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab (1992) 1.16
Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J (1998) 1.16
Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. J Biol Chem (1999) 1.16
Activity and autophosphorylation of LAMMER protein kinases. J Biol Chem (1996) 1.15
Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart (2009) 1.14
Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007. Acta Physiol (Oxf) (2008) 1.14
Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation (2000) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Clonal composition of human adrenocortical neoplasms. Cancer Res (1994) 1.10
Physiological and psychological effects of Hatha-Yoga exercise in healthy women. Int J Psychosom (1994) 1.09
Substance P and nitric oxide signaling in cerebral cortex: anatomical evidence for reciprocal signaling between two classes of interneurons. J Comp Neurol (2001) 1.09
Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson (2006) 1.08
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol (2012) 1.08
Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem (1999) 1.07
Forty-eight new cases with infertility due to balanced chromosomal rearrangements: detailed molecular cytogenetic analysis of the 90 involved breakpoints. Int J Mol Med (2007) 1.07
Development of a technology for automation and miniaturization of protein crystallization. J Biotechnol (2001) 1.07
Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab (1998) 1.06
Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab (1990) 1.06
Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation. Biochem Biophys Res Commun (1991) 1.06
Adrenal tumors: how to establish malignancy ? J Endocrinol Invest (2004) 1.05
Normal V(D)J recombination in cells from patients with Nijmegen breakage syndrome. Mol Immunol (2000) 1.05
Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation (1999) 1.05
Ancillary production and the size of physicians' practice. Inquiry (1976) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. Hum Pathol (2000) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
7 Tesla (T) human cardiovascular magnetic resonance imaging using FLASH and SSFP to assess cardiac function: validation against 1.5 T and 3 T. NMR Biomed (2011) 1.03